Cargando…

Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury

BACKGROUND: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rong-Shuang, Zhou, Jiao-Jiao, Feng, Yu-Ying, Shi, Min, Guo, Fan, Gou, Shen-Ju, Salerno, Stephen, Ma, Liang, Fu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598327/
https://www.ncbi.nlm.nih.gov/pubmed/28836571
http://dx.doi.org/10.4103/0366-6999.213406
_version_ 1783263882631970816
author Huang, Rong-Shuang
Zhou, Jiao-Jiao
Feng, Yu-Ying
Shi, Min
Guo, Fan
Gou, Shen-Ju
Salerno, Stephen
Ma, Liang
Fu, Ping
author_facet Huang, Rong-Shuang
Zhou, Jiao-Jiao
Feng, Yu-Ying
Shi, Min
Guo, Fan
Gou, Shen-Ju
Salerno, Stephen
Ma, Liang
Fu, Ping
author_sort Huang, Rong-Shuang
collection PubMed
description BACKGROUND: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the role of macrophage Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. METHODS: C57BL/6 mice were injected with a 50% glycerin solution at bilateral back limbs to induce rhabdomyolysis, and CLI-095 or pyrrolidine dithiocarbamate (PDTC) was intraperitoneally injected at 0.5 h before molding. Serum creatinine levels, creatine kinase, the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, and hematoxylin and eosin stainings of kidney tissues were tested. The infiltration of macrophage, mRNA levels, and protein expression of TLR4 and NF-κB were investigated by immunofluorescence double-staining techniques, reverse transcriptase-quantitative polymerase chain reaction, and Western blotting, respectively. In vitro, macrophage RAW264.7 was stimulated by ferrous myoglobin; the cytokines, TLR4 and NF-κB expressions were also detected. RESULTS: In an in vivo study, using CLI-095 or PDTC to block TLR4/NF-κB, functional and histologic results showed that the inhibition of TLR4 or NF-κB alleviated glycerol-induced renal damages (P < 0.01). CLI-095 or PDTC administration suppressed proinflammatory cytokine (TNF-α, IL-6, and IL-1β) production and macrophage infiltration into the kidney (P < 0.01). Moreover, in an in vitro study, CLI-095 or PDTC suppressed myoglobin-induced expression of TLR4, NF-κB, and proinflammatory cytokine levels in macrophage RAW264.7 cells (P < 0.01). CONCLUSION: The pharmacological inhibition of TLR4/NF-κB exhibited protective effects on rhabdomyolysis-induced AKI by the regulation of proinflammatory cytokine production and macrophage infiltration.
format Online
Article
Text
id pubmed-5598327
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55983272017-09-22 Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury Huang, Rong-Shuang Zhou, Jiao-Jiao Feng, Yu-Ying Shi, Min Guo, Fan Gou, Shen-Ju Salerno, Stephen Ma, Liang Fu, Ping Chin Med J (Engl) Original Article BACKGROUND: Acute kidney injury (AKI) is the most common and life-threatening systemic complication of rhabdomyolysis. Inflammation plays an important role in the development of rhabdomyolysis-induced AKI. This study aimed to investigate the kidney model of AKI caused by rhabdomyolysis to verify the role of macrophage Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. METHODS: C57BL/6 mice were injected with a 50% glycerin solution at bilateral back limbs to induce rhabdomyolysis, and CLI-095 or pyrrolidine dithiocarbamate (PDTC) was intraperitoneally injected at 0.5 h before molding. Serum creatinine levels, creatine kinase, the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, and hematoxylin and eosin stainings of kidney tissues were tested. The infiltration of macrophage, mRNA levels, and protein expression of TLR4 and NF-κB were investigated by immunofluorescence double-staining techniques, reverse transcriptase-quantitative polymerase chain reaction, and Western blotting, respectively. In vitro, macrophage RAW264.7 was stimulated by ferrous myoglobin; the cytokines, TLR4 and NF-κB expressions were also detected. RESULTS: In an in vivo study, using CLI-095 or PDTC to block TLR4/NF-κB, functional and histologic results showed that the inhibition of TLR4 or NF-κB alleviated glycerol-induced renal damages (P < 0.01). CLI-095 or PDTC administration suppressed proinflammatory cytokine (TNF-α, IL-6, and IL-1β) production and macrophage infiltration into the kidney (P < 0.01). Moreover, in an in vitro study, CLI-095 or PDTC suppressed myoglobin-induced expression of TLR4, NF-κB, and proinflammatory cytokine levels in macrophage RAW264.7 cells (P < 0.01). CONCLUSION: The pharmacological inhibition of TLR4/NF-κB exhibited protective effects on rhabdomyolysis-induced AKI by the regulation of proinflammatory cytokine production and macrophage infiltration. Medknow Publications & Media Pvt Ltd 2017-09-20 /pmc/articles/PMC5598327/ /pubmed/28836571 http://dx.doi.org/10.4103/0366-6999.213406 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Huang, Rong-Shuang
Zhou, Jiao-Jiao
Feng, Yu-Ying
Shi, Min
Guo, Fan
Gou, Shen-Ju
Salerno, Stephen
Ma, Liang
Fu, Ping
Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_full Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_fullStr Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_full_unstemmed Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_short Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury
title_sort pharmacological inhibition of macrophage toll-like receptor 4/nuclear factor-kappa b alleviates rhabdomyolysis-induced acute kidney injury
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598327/
https://www.ncbi.nlm.nih.gov/pubmed/28836571
http://dx.doi.org/10.4103/0366-6999.213406
work_keys_str_mv AT huangrongshuang pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT zhoujiaojiao pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT fengyuying pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT shimin pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT guofan pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT goushenju pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT salernostephen pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT maliang pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury
AT fuping pharmacologicalinhibitionofmacrophagetolllikereceptor4nuclearfactorkappaballeviatesrhabdomyolysisinducedacutekidneyinjury